{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:07:48Z","timestamp":1791126468191,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Persistent airflow limitation can develop in nonsmoking patients with asthma. However, the prevalence and risk factors for airways obstruction with incomplete reversibility in asthma are unknown. We assessed the prevalence of persistent airflow limitation (defined as postbronchodilator FEV1 or FEV1\/VC &amp;lt; 75% predicted) in 132 nonsmoking outpatients with severe asthma visiting chest physicians in general hospitals in The Netherlands. They had used inhaled corticosteroids (\u2a7e 1,600 \u03bc g\/d) and\/or daily oral prednisone and long-acting bronchodilators for &amp;gt; 1 yr. In addition, we examined whether persistent airways obstruction in these patients was associated with specific clinical characteristics (age at onset, smoking history, atopic status, bronchodilator reversibility, provocative concentration of histamine causing a 20% decrease in FEV1 [PC20histamine]) or markers of inflammation (exhaled nitric oxide [NO], blood eosinophils, total IgE; and eosinophilia or neutrophilia in induced sputum). Multiple logistic regression analyses were used to calculate adjusted odds ratios (OR). Persistent airflow limitation was observed in 49% of the patients in the study, and apart from older age and longer asthma duration, was strongly associated with a sputum eosinophils percent \u2a7e 2% (OR = 7.7; confidence interval [CI]: 2.4 to 25), PC20histamine \u2a7d 1.0 mg\/ml (OR = 3.9; CI: 1.2 to 13), and adult onset (\u2a7e 18 yr) of asthma (OR = 3.3; CI: 1.2 to 9). Only sputum eosinophilia appeared to be independently associated with persistent airflow limitation (OR = 8.9; CI: 1.3 to 59). In conclusion, persistent airflow limitation is common in adult patients with severe asthma, and is associated with adult onset of the disease, airway hyperresponsiveness, and most importantly, sputum eosinophilia. These findings suggest that eosinophilic airway inflammation contributes to persistent airflow limitation in severe asthma. Whether reduction of sputum eosinophils with more vigorous treatment leads to a better prognosis in severe asthma is still an open question.<\/jats:p>","DOI":"10.1164\/ajrccm.164.5.2011026","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:50:43Z","timestamp":1365087043000},"page":"744-748","source":"Crossref","is-referenced-by-count":285,"title":["Factors Associated with Persistent Airflow Limitation in Severe Asthma"],"prefix":"10.1093","volume":"164","author":[{"given":"ANNEKE","family":"ten BRINKE","sequence":"first","affiliation":[{"name":"Department of Pulmonary Diseases, Leiden University Medical Center, and Department of Medical Statistics, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AEILKO H.","family":"ZWINDERMAN","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Leiden University Medical Center, and Department of Medical Statistics, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETER J.","family":"STERK","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Leiden University Medical Center, and Department of Medical Statistics, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KLAUS F.","family":"RABE","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Leiden University Medical Center, and Department of Medical Statistics, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELISABETH H.","family":"BEL","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Leiden University Medical Center, and Department of Medical Statistics, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,9,1]]},"reference":[{"key":"2026032708052922400_B1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/thx.39.2.131","article-title":"Asthma and irreversible airflow obstruction.","volume":"39","author":"Brown","year":"1984","journal-title":"Thorax"},{"key":"2026032708052922400_B2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199810223391703","article-title":"A 15-year follow-up study of ventilatory function in adults with asthma.","volume":"339","author":"Lange","year":"1998","journal-title":"N Engl J Med"},{"key":"2026032708052922400_B3","first-page":"171","article-title":"Rate of decline of lung function in subjects with asthma.","volume":"70","author":"Peat","year":"1987","journal-title":"Eur J Respir Dis"},{"key":"2026032708052922400_B4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/thx.47.1.14","article-title":"A 10-year follow-up of 180 adults with bronchial asthma: factors important for the decline in lung function.","volume":"47","author":"Ulrik","year":"1992","journal-title":"Thorax"},{"key":"2026032708052922400_B5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1183\/09031936.98.12051209","article-title":"Difficult asthma.","volume":"12","author":"Barnes","year":"1998","journal-title":"Eur Respir J"},{"key":"2026032708052922400_B6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0272-5231(05)70270-7","article-title":"Consequences of long-term inflammation. Airway remodeling.","volume":"21","author":"Homer","year":"2000","journal-title":"Clin Chest Med"},{"key":"2026032708052922400_B7","first-page":"53","article-title":"Persistent peripheral airway obstruction in children with severe asthma.","volume":"63","author":"Akhter","year":"1989","journal-title":"Ann Allergy"},{"key":"2026032708052922400_B8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0954-6111(98)90290-6","article-title":"Peripheral airways obstruction on high-resolution computed tomography in chronic severe asthma.","volume":"92","author":"Carr","year":"1998","journal-title":"Respir Med"},{"key":"2026032708052922400_B9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1164\/ajrccm.159.4.9807121","article-title":"Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.","volume":"159","author":"Hansen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B10","doi-asserted-by":"crossref","first-page":"S535","DOI":"10.1016\/S0091-6749(00)90057-5","article-title":"Natural history of chronic asthma and its long-term effects on pulmonary function.","volume":"105","author":"McFadden","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708052922400_B11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1034\/j.1399-3003.1999.13d35.x","article-title":"Outcome of asthma: longitudinal changes in lung function.","volume":"13","author":"Ulrik","year":"1999","journal-title":"Eur Respir J"},{"key":"2026032708052922400_B12","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1164\/ajrccm.160.6.9812100","article-title":"Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years: a 30-year follow-up study.","volume":"160","author":"Grol","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/ajrccm.153.2.8564098","article-title":"Skin test reactivity to common aeroallergens and decline of lung function: The Normative Aging Study.","volume":"153","author":"Gottlieb","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0091-6749(91)90243-H","article-title":"Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample.","volume":"88","author":"Burrows","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708052922400_B15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1164\/ajrccm.150.3.8087330","article-title":"Decline of lung function in adults with bronchial asthma.","volume":"150","author":"Ulrik","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0272-5231(05)70269-0","article-title":"Consequences of long-term inflammation: the natural history of asthma.","volume":"21","author":"Sears","year":"2000","journal-title":"Clin Chest Med"},{"key":"2026032708052922400_B17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/ajrccm\/143.5_Pt_1.987","article-title":"Blood eosinophilia and FEV1: cross-sectional and longitudinal analyses.","volume":"143","author":"Frette","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2026032708052922400_B18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1081-1206(10)63072-4","article-title":"Eosinophils and pulmonary function: an epidemiologic study of adolescents and young adults.","volume":"80","author":"Ulrik","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026032708052922400_B19","first-page":"1198","article-title":"Difficult\/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult\/Therapy-Resistant Asthma. European Respiratory Society.","volume":"13","author":"Chung","year":"1999","journal-title":"Eur Respir J"},{"key":"2026032708052922400_B20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"key":"2026032708052922400_B21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/09041950.053s1693","article-title":"Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.","volume":"16","author":"Sterk","year":"1993","journal-title":"Eur Respir J Suppl"},{"key":"2026032708052922400_B22","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199211123272003","article-title":"A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.","volume":"327","author":"Kerstjens","year":"1992","journal-title":"N Engl J Med"},{"key":"2026032708052922400_B23"},{"key":"2026032708052922400_B24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1183\/09031936.98.11010126","article-title":"Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects.","volume":"11","author":"de Gouw","year":"1998","journal-title":"Eur Respir J"},{"key":"2026032708052922400_B25"},{"key":"2026032708052922400_B26"},{"key":"2026032708052922400_B27","first-page":"858","article-title":"The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials: influence of clinical diagnosis, spirometric, and anthropometric variables.","volume":"132","author":"Eliasson","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2026032708052922400_B28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0091-6749(05)80037-5","article-title":"Sensitivity and specificity of histamine PC20 determination in a random selection of young college students.","volume":"89","author":"Cockcroft","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708052922400_B29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1164\/ajrccm.159.3.9802108","article-title":"Exhaled nitric oxide measurements in a population sample of young adults.","volume":"159","author":"Salome","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/ajrccm.161.2.9903097","article-title":"Induced sputum cell counts in healthy adults.","volume":"161","author":"Belda","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1034\/j.1399-3003.1999.14d27.x","article-title":"Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma.","volume":"14","author":"Ulrik","year":"1999","journal-title":"Eur Respir J"},{"key":"2026032708052922400_B32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0002-9343(47)90204-0","article-title":"A working classification of asthma.","volume":"3","author":"Rackemann","year":"1947","journal-title":"Am J Med"},{"key":"2026032708052922400_B33","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/ajrccm.151.5.7735588","article-title":"Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1.","volume":"151","author":"Rijcken","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1399-3003.2000.15b05.x","article-title":"Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre.","volume":"15","author":"Ichinose","year":"2000","journal-title":"Eur Respir J"},{"key":"2026032708052922400_B35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF00402221","article-title":"Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts.","volume":"286","author":"Birkland","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"2026032708052922400_B37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2249.1991.tb05793.x","article-title":"Eosinophils adhere to and stimulate replication of lung fibroblasts in vitro.","volume":"86","author":"Shock","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2026032708052922400_B38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1165\/ajrcmb.17.3.2733","article-title":"Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma.","volume":"17","author":"Minshall","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032708052922400_B39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma.","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"2026032708052922400_B40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0091-6749(97)70193-3","article-title":"Inflammation of small airways in asthma.","volume":"100","author":"Hamid","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708052922400_B41","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1164\/ajrccm.159.5.9804131","article-title":"Increased glucocorticoid receptor-beta in airway cells of glucocorticoid-insensitive asthma.","volume":"159","author":"Hamid","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708052922400_B42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0091-6749(99)70118-1","article-title":"Eosinophilic airway inflammation in nasal polyposis.","volume":"104","author":"Lamblin","year":"1999","journal-title":"J Allergy Clin Immunol"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/164\/5\/744\/67580598\/ajrccm_164_5_744.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/164\/5\/744\/67580598\/ajrccm_164_5_744.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:05:38Z","timestamp":1774613138000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/164\/5\/744\/8544660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,1]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2001,9,1]]},"published-print":{"date-parts":[[2001,9,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.164.5.2011026","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,9]]},"published":{"date-parts":[[2001,9,1]]}}}